These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 13862726)
21. Technique and results of isolation of cancer cells from the circulating blood. ROBERTS S; WATNE A; McGRATH R; McGREW E; COLE WH AMA Arch Surg; 1958 Mar; 76(3):334-46. PubMed ID: 13507823 [No Abstract] [Full Text] [Related]
22. [Blood glycoproteins in malignant diseases]. PAGNI G Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Apr; 13():204-14. PubMed ID: 14429792 [No Abstract] [Full Text] [Related]
23. [The properdin level in neoplasms and in malignant blood diseases]. DIOMEDE-FRESA V; FUMAROLA A Prog Med (Napoli); 1959 May; 15():310-4. PubMed ID: 13816890 [No Abstract] [Full Text] [Related]
24. [Determination and registration of the oxidation-reduction potential of venous blood in normal subjects and in cancer patients]. BLANQUET P; ARNAUD Y Bull Assoc Fr Etud Cancer; 1955; 42(4):504-15. PubMed ID: 13329462 [No Abstract] [Full Text] [Related]
25. [Clinical study of the Miyamoto-Inagaki's phenomenon of blood serum. X. Effect of radiation therapy on malignant tumors]. ISOME S Gan; 1955 Sep; 46(2-3):439-40. PubMed ID: 13262446 [No Abstract] [Full Text] [Related]
26. [Studies on the serum protein in patients with malignant tumor]. WARABIOKA K Gan; 1955 Sep; 46(2-3):117-20. PubMed ID: 13262294 [No Abstract] [Full Text] [Related]
27. [The variations of mucoproteins of the blood in malignant neoplasms, in the course of telecobaltotherapy (preliminary experience)]. VECCHI C; BETTINI F; GIANNARDI G Riv Clin Pediatr; 1959 Jun; 63():526-31. PubMed ID: 13841519 [No Abstract] [Full Text] [Related]
28. [Experimental studies on the hyaluronic acid-hyaluronidase problem, especially in malignant diseases]. BUCHNER M; SCHONE W Hoppe Seylers Z Physiol Chem; 1956 Mar; 303(3-6):102-6. PubMed ID: 13331464 [No Abstract] [Full Text] [Related]
29. [Blood groups and tumors]. BENDA N; GAMBELUNGHE C Riforma Med; 1962 Mar; 76():266-8. PubMed ID: 13867067 [No Abstract] [Full Text] [Related]
30. [Peripheral erythroblastosis in cancer in the absence of anemia]. METZGER H; LEVY JG Sang; 1951; 22(7):588-91. PubMed ID: 14876305 [No Abstract] [Full Text] [Related]
31. [Considerations on results of certain colloidal reactions of blood in malignant blastomas]. DAGRADI A Acta Chir Patav; 1952; 8(1-2):111-8. PubMed ID: 12985081 [No Abstract] [Full Text] [Related]
32. ANAEMIA in malignant disease. Br Med J; 1956 Mar; 1(4965):501-2. PubMed ID: 13293368 [No Abstract] [Full Text] [Related]
33. [Cancer and variations of blood phosphate in relation to carbohydrate metabolism]. REYMOND C; WILD C Oncologia; 1953; 6(2):148-57. PubMed ID: 13063898 [No Abstract] [Full Text] [Related]
34. Anemia and other hematologic abnormalities as manifestations of malignant disease. HAGEDORN AB Ill Med J; 1962 Apr; 121():365-8. PubMed ID: 13903579 [No Abstract] [Full Text] [Related]
35. The clinical features of hypercalcemia associated with malignant disease. WARWICK OH; YENDT ER; OLIN JS Can Med Assoc J; 1961 Sep; 85(13):719-23. PubMed ID: 13783268 [No Abstract] [Full Text] [Related]
36. [Sulfhydryl groups in components of blood and marrow of subjects with neoplasms and malignant granuloma; cytotopochemical research]. CAMPANACCI L; TURA S Boll Soc Ital Biol Sper; 1955; 31(11-12):1502-5. PubMed ID: 13329192 [No Abstract] [Full Text] [Related]
37. The level of serum neuraminic acid in malignant neoplasms and other pathologic conditions. KATCHMAN BJ; MURPHY JP; ZIPF RE Am J Clin Pathol; 1961 Jun; 35():495-503. PubMed ID: 13751747 [No Abstract] [Full Text] [Related]
38. Tumour cells in the blood. SALGADO I; HOPKIRK JF; LONG RC; RITCHIE AC; RITCHIE S; WEBSTER DR Can Med Assoc J; 1959 Oct; 81(8):619-22. PubMed ID: 14440980 [No Abstract] [Full Text] [Related]
39. The significance of cancer cells in the blood. MOORE GE Surg Gynecol Obstet; 1960 Mar; 110():360-1. PubMed ID: 14423856 [No Abstract] [Full Text] [Related]